PHILADELPHIA — Discharge Decision Support System, a tool to improve health-care outcomes based on research conducted at the University of Pennsylvania School of Nursing, is the winner of the Janssen Connected Care Challenge and a $100,000 prize, awarded by Janssen Healthcare Innovation, part of Janssen Research & Development, LLC.
PHILADELPHIA — By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement strategy to track down parasites that is similar to strategies that predators such as monkeys, sharks and blue-fin tuna use to hunt their prey.
Philadelphia, PA – The University of Pennsylvania’s Graduate School of Education (Penn GSE) and the Milken Family Foundation have announced the finalists of the 2012 Milken-Penn GSE Education Business Plan Competition (EBPC).
Philip Gehrman of the Perelman School of Medicine shares his thoughts on a new study about sleepwalking.
Ben Voight of the Perelman School of Medicine is mentioned as co-author of a study about HDL levels.
Media Contact:Colby Bishop | firstname.lastname@example.org | 202-828-8075May 17, 2012
A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab. This proof-of-concept study is published this week in Science Translational Medicine.
A new study published by researchers at the Perelman School of Medicine at the University of Pennsylvania, the Broad Institute, and Massachusetts General Hospital, challenges the conventional concept that raising a person's HDL levels (good cholesterol) will always help lower their risk of a heart attack.